Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients with Migraine- Results from Two Global Phase 3 Clinical Trials

May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.1413
https://www.valueinhealthjournal.com/article/S1098-3015(18)31719-4/fulltext
Section Title :
Section Order : 658
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31719-4&doi=10.1016/j.jval.2018.04.1413
HEOR Topics :
Tags :
Regions :